A clinical study to evaluate the effect of Matrustanya in Opthalmia neonatarum.

RANDOMIZED CONTROLLED CLINICAL TRIAL TO COMPARE THE EFFICACY OF MATRU STANYA AASCHOTANA WITH TOBRAMYCIN EYE DROP IN KUKUNAKA (OPTHALMIA NEONATARUM) IN NEONATES - Nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/02/062498

Enrollment

Registered

2024-02-09

Start date

Unknown

Completion date

Unknown

Last updated

2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H109- Unspecified conjunctivitis

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Neonates suffering from Kukunaka term baby Neonate 0 to 28 days Babies weight greater than 2500 gm Parents willing for treatment

Exclusion criteria

Exclusion criteria: preterm babies baby weight less than 2500 gm lacrimal duct atresia NICU babies

Design outcomes

Primary

Measure	Time frame
No itching, lacrimation,photophobia, congestionTimepoint: 1,2,3,4,5,6,7,8th	—

Secondary

Measure	Time frame
decrease irritability due to Itching, decrease lacrimation & congestion, taking feed wellTimepoint: 1,2,3,4,5,6,7,8th	—

Countries

India

Contacts

Public ContactDr Vikas Jaybhay

Tilak Ayurved Mahavidhyalaya Rasta Peth Pune

vikasjaybhay110@gmail.com8888587158

Outcome results